1. Home
  2. GGT vs SCLX Comparison

GGT vs SCLX Comparison

Compare GGT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Multi-Media Trust Inc. (The)

GGT

Gabelli Multi-Media Trust Inc. (The)

HOLD

Current Price

$4.20

Market Cap

144.8M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$16.48

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGT
SCLX
Founded
1994
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.8M
139.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GGT
SCLX
Price
$4.20
$16.48
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
59.7K
121.9K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
15.56%
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
N/A
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
$6.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.32
$3.60
52 Week High
$7.00
$34.27

Technical Indicators

Market Signals
Indicator
GGT
SCLX
Relative Strength Index (RSI) 55.69 41.66
Support Level $4.16 $18.34
Resistance Level $4.32 $20.62
Average True Range (ATR) 0.05 1.46
MACD 0.02 -0.39
Stochastic Oscillator 59.09 3.10

Price Performance

Historical Comparison
GGT
SCLX

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: